Sheena Aurora, MD, medical fellow and global launch leader, Eli Lilly and Company, Indianapolis.
Migraine relief may soon include lasmiditan, the first in a new class of migraine drug in 20 years—rapid relief without heart and blood pressure risks.
Read More >
